Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christos A Michalakeas

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Reviews on Recent Clinical Trials|January 19, 2011
The role of lipoprotein-associated phospholipase A2 (Lp-PLA₂) in cardiovascular diseaseIgnatios Ikonomidis, Christos A Michalakeas, John Lekakis, et al.
Disease Markers|September 24, 2009
Multimarker approach in cardiovascular risk predictionIgnatios Ikonomidis, Christos A Michalakeas, John Lekakis, et al.
ISRN Oncology|November 18, 2011
Cardiac tumorsIoannis A Paraskevaidis, Christos A Michalakeas, Constantinos H Papadopoulos, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|December 21, 2010
Differential diagnosis of a left atrial mass: role of three-dimensional transoesophageal echocardiographyConstantinos H Papadopoulos, Christos A Michalakeas, Ioannis Paraskevaidis, et al.
Biofactors (Oxford, England)|May 26, 2012
Inflammatory markers in coronary artery diseaseIgnatios Ikonomidis, Christos A Michalakeas, John Parissis, et al.
Recent Patents on Cardiovascular Drug Discovery|December 24, 2013
Canagliflozin: a new hope in the antidiabetic armamentariumVasiliki K Katsi, Christos A Michalakeas, Charalambos E Grassos, et al.
Journal of Cardiac Failure|August 30, 2011
Effects of sertraline on circulating markers of oxidative stress in depressed patients with chronic heart failure: a pilot studyChristos A Michalakeas, John T Parissis, Athanasios Douzenis, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Reviews on Recent Clinical Trials|January 19, 2011
The role of lipoprotein-associated phospholipase A2 (Lp-PLA₂) in cardiovascular diseaseIgnatios Ikonomidis, Christos A Michalakeas, John Lekakis, et al.
Disease Markers|September 24, 2009
Multimarker approach in cardiovascular risk predictionIgnatios Ikonomidis, Christos A Michalakeas, John Lekakis, et al.
ISRN Oncology|November 18, 2011
Cardiac tumorsIoannis A Paraskevaidis, Christos A Michalakeas, Constantinos H Papadopoulos, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|December 21, 2010
Differential diagnosis of a left atrial mass: role of three-dimensional transoesophageal echocardiographyConstantinos H Papadopoulos, Christos A Michalakeas, Ioannis Paraskevaidis, et al.
Biofactors (Oxford, England)|May 26, 2012
Inflammatory markers in coronary artery diseaseIgnatios Ikonomidis, Christos A Michalakeas, John Parissis, et al.
Recent Patents on Cardiovascular Drug Discovery|December 24, 2013
Canagliflozin: a new hope in the antidiabetic armamentariumVasiliki K Katsi, Christos A Michalakeas, Charalambos E Grassos, et al.
Journal of Cardiac Failure|August 30, 2011
Effects of sertraline on circulating markers of oxidative stress in depressed patients with chronic heart failure: a pilot studyChristos A Michalakeas, John T Parissis, Athanasios Douzenis, et al.
Pageof 1